Viatris inc. and kindeva drug delivery announce fda tentative approval of the first abbreviated new drug application generic version of symbicort® (budesonide/formoterol fumarate dihydrate) inhalation aerosol

Pittsburgh and st. paul, minn., march 8, 2021 /prnewswire/ -- viatris inc. (nasdaq: vtrs) and kindeva drug delivery l.p. today announced that the u.s. food and drug administration (fda) granted tentative approval of budesonide/formoterol fumarate dihydrate products, the first generic...
VTRS Ratings Summary
VTRS Quant Ranking